Healthcare

UnitedHealth Group is confronting a pivotal moment in its corporate history. For the first time in more than three decades,...

Eli Lilly & Co. is executing a rapid and ambitious strategy to broaden its therapeutic reach. In a concentrated burst...

The telemedicine provider Hims & Hers is navigating a complex competitive landscape. Amid recent pressure on its share price, the...

Biotechnology firm VolitionRX Ltd. enters a critical period marked by two significant corporate developments: the release of fresh clinical study...

ImmunityBio has entered 2026 with significant momentum, propelled by a confluence of fresh clinical data, key regulatory communications, and international...

CVS Health is confronting significant margin pressure after U.S. health program administrators announced a reimbursement rate adjustment that fell dramatically...

A period of aggressive acquisitions and strategic refocusing defined 2025 for Healwell AI, dramatically reshaping its financial profile. However, the...

Investor attention has returned to BioNxt Solutions following the release of encouraging new laboratory data. The company's latest preclinical study...

The healthcare behemoth UnitedHealth is embarking on a significant strategic shift, prioritizing long-term stability over immediate profits. In a move...

BioNxt Solutions Inc. has announced a key preclinical milestone for its experimental multiple sclerosis therapy. The Canadian biotechnology firm’s innovative...